The role of botulinum toxin in multimodal treatment of spasticity in ambulatory children with spastic Cerebral Palsy: extensive evaluation of a cost-effectiveness trial.

Bussmann JBJ, Pangalila RF, Stam HJ, Schasfoort F. J Rehabil Med. 2020 May 29;52(5):jrm00059. doi: 10.2340/16501977-2680. PMID: 32301499.

Relationship between changes in motor capacity and objectively measured motor performance in ambulatory children with spastic cerebral palsy.

Halma E, Bussmann JBJ, van den Berg-Emons HJG, Sneekes EM, Pangalila R, Schasfoort FC; Child Care Health Dev. 2020 Jan;46(1):66-73. doi: 10.1111 / cch.12719. Epub 2019 Dec 3. PMID: 31756281; PMCID: PMC7004060.